Depression screenings: developing a model for use in a community pharmacy.
To develop a depression screening model that can be replicated by other community pharmacists, conduct a depression screening in a community pharmacy, identify and appropriately refer patients with symptoms consistent with depression. Uncontrolled study. Four supermarkets in the Kansas City, Kans. and Mo" metropolitan area, on January 25, 2003. 18 supermarket shoppers, 6 community pharmacists, and 4 psychiatric pharmacy specialists. Identification of symptoms consistent with major depressive disorder (MDD). The feasibility and effectiveness of developed depression screening; identify and appropriately refer patients with symptoms consistent with depression. The depression screening model was tested as a pilot project to evaluate its feasibility and effectiveness. The mean (+/- SD) total score on the 10-item Harvard Department of Psychiatry/National Depression Screening Day Scale (HANDS) tool was 5.8 +/- 5.0. Overall, of 18 total participants, 14 were unlikely to have symptoms of MDD, 3 had symptoms consistent with MDD (including 1 reporting recent suicidal thinking), and 1 had symptoms strongly consistent with MDD. Patients followed the pharmacist's referral recommendations in all cases. The HANDS tool is easily used in community pharmacy as a screening form. With training, community pharmacists are capable of performing screenings and referring patients.